No Access
Industry Watch
https://doi.org/10.1142/S0219030304001065Cited by:0 (Source: Crossref)
Abstract
AustCancer and Sloan-Kettering in Cancer Drug Clinical Trials Collaboration.
GTG Grants Licenses Non-Coding Technologies to Ovita.
Regenera Subsidiary Obtain Patent in Diabetic Eye Steroid.
Roche New R&D Center Established in Shanghai.
Pharmaceutical Product Transaction in the 94th Canton Fair.
New GMP Purification Facility in Hong Kong.
Japan Generic Drug Market Surge due to Government Incentives.
Fujirebio Launches New Liver Cancer Marker Test Kit.
New Joint Venture in Japan — Zepharma Inc.
Welch Allyn's New Asian Headquarters.
Keywords:
- AustCancer
- Sloan-Kettering
- cancer
- clinical trials
- Galenica Pharmaceuticals
- Genetic Technologies Ltd
- Ovita
- Meat & Wool New Zealand
- Regenera
- diabetes
- Roche
- Zhangjiang Hi-Tech Park
- Canton Fair
- antibiotics
- GMP purification facility
- Advantek Biologics
- Hong Kong Institute of Biotechnology Ltd
- Fujirebio
- CLEIA
- LUMIPULSE
- Zepharma
- Welch Allyn
